Hydrochlorothiazide and risk of melanoma and non-melanoma skin cancer
Non-melanoma skin cancer (NMSC) is thought to be the most commonly diagnosed cancer in Canadians. There are two main types of NMSC, including basal cell
July 15, 2020
Active Surveillance & Canadian multi-province Cohorts of Pregnant Women and Children
Query 19-03: Active Surveillance & Canadian multi-province Cohorts of Pregnant Women and Children. This research is funded by the Drug Safety and Effectiveness Network (DSEN)
July 15, 2020
Canadian Mother-Child Cohort Presentation
Dr. Anick Berard will present The Canadian Mother-Child Cohort Initiative as part of the DSECT/DESN Monthly Seminar Series on Thursday, May 23, 2019 between 3:00
May 14, 2019
Predictors of chronic opioid use in non-cancer community-dwelling patients
High consumption rates of prescription opioids in Canada raised the need to understand factors associated with chronic use to counteract opioid-related harms (addiction, misuse, abuse
April 24, 2019
Comparative effectiveness and safety of biosimilars and legacy drugs
In Canada, and worldwide, there is a need for updated, independent, real-world comparative effectiveness and safety data related to biologic drugs including biosimilar drugs. Our
July 23, 2018
Low dose fluconazole and adverse pregnancy outcomes
Query 16-09: Low dose fluconazole and adverse pregnancy outcomes. This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the
July 23, 2018